뇌졸중 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Stroke Management Market size is expected to reach USD 95.96 Billion in 2034 from USD 49.38 Billion (2025) growing at a CAGR of 7.66% during 2026-2034.

The global stroke management market is expanding steadily due to the rising incidence of stroke cases worldwide. Increasing aging populations, unhealthy lifestyles, and growing prevalence of hypertension and diabetes are major contributing factors. Early diagnosis and timely intervention are critical in stroke treatment, leading to higher demand for advanced imaging systems, thrombolytic drugs, and neurovascular devices.

Major growth drivers include technological advancements in minimally invasive surgical procedures and improved emergency response systems. The adoption of telemedicine and remote monitoring solutions has enhanced access to specialized stroke care, particularly in rural regions. Government initiatives focused on stroke awareness and prevention programs further strengthen market growth.

In the coming years, innovation in neuroprotective drugs and AI-based diagnostic tools is expected to enhance treatment outcomes. Expanding healthcare infrastructure in emerging economies will create additional growth avenues. As awareness about early symptom recognition increases, the demand for comprehensive stroke management solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Diagnostics
• Therapeutics

By Application

• Ischemic Stroke
• Haemorrhagic Stroke

COMPANIES PROFILED

• Aidoc, JLK, Deepnoid Co Ltd, VasSol Inc, B Braun SE, Cardinal Health, Siemens AG, Medtronic, NeuraSignal Inc, Abbott Laboratories, METHINKS, Boston Scientific Corporation, Merck Co Inc, Heuron Co Ltd, BristolMyers Squibb Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STROKE MANAGEMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STROKE MANAGEMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ischemic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Haemorrhagic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STROKE MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL STROKE MANAGEMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Aidoc
  • 8.2.2 JLK
  • 8.2.3 Deepnoid Co. Ltd
  • 8.2.4 VasSol Inc
  • 8.2.5 B. Braun SE
  • 8.2.6 Cardinal Health
  • 8.2.7 Siemens AG
  • 8.2.8 Medtronic
  • 8.2.9 NeuraSignal Inc
  • 8.2.10 Abbott Laboratories
  • 8.2.11 METHINKS
  • 8.2.12 Boston Scientific Corporation
  • 8.2.13 Merck & Co. Inc
  • 8.2.14 Heuron Co. Ltd
  • 8.2.15 Bristol-Myers Squibb Company